A. Layton

Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group

B. Elewski, M. Picardo, Z. Draelos, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study

M. Schaller, D. Sarwer, A. Bewley, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

A review on the treatment of acne vulgaris

A. Layton, 2005, International journal of clinical practice.

European Evidence-based (S3) Guideline for the Treatment of Acne

B. Dréno, A. Finlay, H. Gollnick, 2016 .

A randomized, single‐blind comparison of topical clindamycin + benzoyl peroxide (Duac®) and erythromycin + zinc acetate (Zineryt®) in the treatment of mild to moderate facial acne vulgaris

A. Layton, A. Langner, R. Sheehan-Dare, 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

European evidence‐based (S3) guideline for the treatment of acne – update 2016 – short version

B. Dréno, A. Finlay, H. Gollnick, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adult female acne: a new paradigm

B. Dréno, J. López-Estebaranz, J. Harper, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Large‐scale international study enhances understanding of an emerging acne population: adult females

B. Dréno, D. Thiboutot, D. Berson, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Interleukin‐10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris

J. Cove, A. Layton, E. Eady, 2010, The British journal of dermatology.

Ineffective consultations for acne: what is important to patients?

A. Layton, M. Ridd, F. Cowdell, 2016, The British journal of dermatology.